Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000604668 | SCV000699628 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706681 | SCV000715255 | likely benign | not provided | 2021-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001486600 | SCV001691060 | likely benign | RASopathy | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813513 | SCV002060802 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160002 | SCV003913135 | likely benign | Cardiovascular phenotype | 2022-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001706681 | SCV005050717 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | MAP2K2: BP4, BP7 |